Showing results (311-320 of 367) with videos related to
Sort By:
Pageof 37
Journal of the National Comprehensive Cancer Network : JNCCN|September 2, 2020
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 PandemicElizabeth A Griffiths, Laura M Alwan, Kimo Bachiashvili, et al.The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.Environmental Science & Technology|July 12, 2023
Low-Cost Sensor Performance Intercomparison, Correction Factor Development, and 2+ Years of Ambient PM2.5 Monitoring in Accra, GhanaGarima Raheja, James Nimo, Emmanuel K-E Appoh, et al.JAMA|April 21, 2011
Use of whole-genome sequencing to diagnose a cryptic fusion oncogeneJohn S Welch, Peter Westervelt, Li Ding, et al.Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of TP53 -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 15, 2011
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromesPeter L Greenberg, Eyal Attar, John M Bennett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic TransplantationStephanie J Lee, Brent Logan, Mary M Horowitz, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Myeloid growth factorsJeffrey Crawford, James Armitage, Lodovico Balducci, et al.Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.Pageof 37